protein

Recombinant Human CCAAT/enhancer binding protein(C/EBP) Alpha

MBS142987

0.01 mg

140 USD

Recombinant Protein

Recombinant Human CCAAT/enhancer binding protein(C/EBP) Alpha

CCAAT/enhancer binding protein(C/EBP) Alpha

CEBP Alpha Human; CCAAT/enhancer binding protein CEBP Alpha Human Recombinant; CCAAT/enhancer-binding protein alpha; C/EBP alpha; CEBPA; CEBP

CCAAT/enhancer-binding protein alpha isoform a; CCAAT/enhancer-binding protein alpha; CCAAT/enhancer-binding protein alpha; CCAAT/enhancer binding protein (C/EBP), alpha

CEBP-a

CEBPA; CEBPA; CEBP; C/EBP-alpha; C/EBP alpha

CEBPA_HUMAN

E Coli

358

MRGSHHHHHH GMASMTGGQQ MGRDlYDDDD KDRWGSMGAG KAKKSVDKNS NEYRVRRERN NIAVRKSRDK AKQRNVETQQ KVLELTSDND RLRKRVEQLS RELDTLRGIF RQLPESSLVKAMG NCA.

Greater than 95.0% as determined by SDS-PAGE.

The protein (lmg/ml) contains 20mM Tris-HCI pH7.5, 0.lM NaCl and 5mM beta~Mercaptoethanol. Physical Appearance: Sterile filtered colorless solution.

lmg/ml

Store at 4 degree C if entire vial will be used within 2-4 weeks. Store, frozen at -20 degree C for longer periods of time. Please avoid freeze thaw cycles.

RECOMBINANT & NATURAL PROTEINS; Recombinant Proteins; CCAAT/enhancer binding protein

Description: CEBP-a Human Recombinant His-Tag fusion protein produced in E Coli is a single, non-glycosylated polypeptide chain containing amino acids 126 (aa 270-358) and having a molecular mass of 14.5 kDa. The Recombinant Human CEBP-a was purified by proprietary chromatographic techniques. Introduction: CCAAT/enhancer binding protein(C/EBP) a is a family of transcription factors that all contain a highly conserved, basic-leucine zipper domain at the C-terminus that is involved in dimerization and DNA binding. C/EBP family of transcription factors regulates viral and cellular CCAAT/enhancer element-mediated transcription. C/EBP family consist of several related proteins, C/EBP a,b,g,d, that form homodimers and that form heterodimers with each other. C/EBP proteins contain the bZIP region, which is characterized by two motifs in the C-terminal half of the protein; a basic region involved in DNA binding and a leucine zipper motif involved in dimerization. C/EBPs differ significantly in their physiological functions and in their downstream target genes. For example, mice lacking C/EBPa die shortly after birth due to severe hypoglycemia and the absence of glycogen storage in liver, whereas knockout of C/EBPb causes defects in female reproduction.

28872794

NP_004355.2

NM_004364.4

P49715

Acute Myeloid Leukemia Pathway (83117); Acute Myeloid Leukemia Pathway (529); Adipogenesis Pathway (198832); C-MYB Transcription Factor Network Pathway (138073); Developmental Biology Pathway (477129); E2F Transcription Factor Network Pathway (137934); EGFR1 Signaling Pathway (198782); FOXA2 And FOXA3 Transcription Factor Networks Pathway (137911); Non-alcoholic Fatty Liver Disease (NAFLD) Pathway (862188); Non-alcoholic Fatty Liver Disease (NAFLD) Pathway (862314)

This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]

C/EBP-alpha: a bZIP transcription factor which can form homodimers or heterodimers with the related proteins CEBP-beta and CEBP-gamma. Binds to the promoter and modulate the expression of the gene encoding leptin, a protein that plays an important role in body weight homeostasis. Can interact with CDK2 and CDK4, thereby inhibiting these kinases and causing growth arrest in cultured cells. Protein type: DNA-binding; Transcription factor. Chromosomal Location of Human Ortholog: 19q13.1. Cellular Component: Rb-E2F complex; nuclear matrix; nucleus. Molecular Function: RNA polymerase II transcription factor activity, enhancer binding; protein binding; protein homodimerization activity; DNA binding; protein heterodimerization activity; protein complex binding; transcription factor binding; transcription factor activity. Biological Process: transcription from RNA polymerase II promoter; fat cell differentiation; embryonic placenta development; macrophage differentiation; viral reproduction; response to glucocorticoid stimulus; cell maturation; negative regulation of transcription from RNA polymerase II promoter; glucose homeostasis; negative regulation of cell proliferation; response to vitamin B2; acute-phase response; inner ear development; cholesterol metabolic process; mitochondrion organization and biogenesis; generation of precursor metabolites and energy; organ regeneration; granulocyte differentiation; transcription, DNA-dependent; cytokine and chemokine mediated signaling pathway; negative regulation of cyclin-dependent protein kinase activity; liver development; positive regulation of osteoblast differentiation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; white fat cell differentiation; brown fat cell differentiation; positive regulation of transcription from RNA polymerase III promoter; positive regulation of fat cell differentiation; positive regulation of transcription from RNA polymerase II promoter; myeloid cell differentiation; lung development; urea cycle. Disease: Leukemia, Acute Myeloid

0.01 mg

140 USD

0.05 mg

205

1 mg

1790